Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

C31G research results reported

June 21, 1996

Caverject cleared for marketing in Canada

June 21, 1996

Lilly's Humalog reaches first market

June 21, 1996

Teikoku Hormone reveals novel octadecapeptide

June 21, 1996

Lilly discloses insulin analogues

June 21, 1996

Ceredase approved in Japan

June 21, 1996

Redux launched in U.S.

June 21, 1996

Research results of SomatoKine as catabolism treatment

June 21, 1996

Astra acquires worldwide rights to ALX1-11

June 21, 1996

Orquest's Healos enters clinical trials

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...